Search Results
Crafting a Comprehensive Cardiovascular Protocol
Seven science-backed interventions to tame inflammation, lower cholesterol, minimize cardiometabolic risk factors and support your patients’ heart health Of all the disease and conditions ...
Read More →
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes ...
Read More →
The Ever-Evolving Microbiome: Part Two
Crafting a personalized probiotic protocol that changes across the lifespan, to meet your patients' needs at every age and stage of life.
Read More →
Beyond Good and Bad: Shifting the Perspective on Cholesterol
Since 1950, heart disease has been the leading cause of death in the United States. And after decades of research, billions of dollars spent on ...
Read More →
The Ever-Evolving Microbiome—Ages and Stages
Research highlights specific patterns and transition points at various ages and stages of life, as well as significant impacts those changes have on long-term wellness—so ...
Read More →
Specific Ingredients Address the Triad of Cardiovascular Concerns
Cholesterol receives the lion’s share of attention regarding heart health, but in reality, cholesterol is part of a triad of factors that need to be ...
Read More →
Understanding Long Covid and an Effective Protocol from Jacob Teitelbaum, MD
In this episode, we talk with Jacob Teitelbaum, MD about long covid and a treatment protocol he is using to improve the quality of life ...
Read More →
L-Ergothioneine: The Mitochondrial Marvel
L-ergothioneine is a naturally occurring amino acid derivative that accumulates within cells, particularly in mitochondria. Mitochondria are cellular organelles known as the powerhouses of ...
Read More →
Scientists Discover Mechanism for Natural Treatment of NASH
Nonalcoholic steatohepatitis (NASH) develops when fat in the liver becomes toxic, killing liver cells and promoting inflammation and fibrosis. The disease can lead to cirrhosis, ...
Read More →
SIBO & NAFLD – Cause, Effect or Bystander?
A recent review published in Nutrients examines the relationship between small intestinal bacterial overgrowth (SIBO) and non-alcoholic fatty liver disease (NAFLD). This relationship has gained research attention, as a growing ...
Read More →